PRISM MEDICO AND PHARMACY LTD.

NSE : NABSE : 512217ISIN CODE : INE730E01016Industry : Finance - InvestmentHouse : Private
BSE25.050.06 (+0.24 %)
PREV CLOSE ( ) 24.99
OPEN PRICE ( ) 25.49
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6346
TODAY'S LOW / HIGH ( )24.35 25.49
52 WK LOW / HIGH ( ) 22.0539.2
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2019Mar2018Mar2017
Profit Before TaxNANANA
AdjustmentNANANA
Changes In working CapitalNANANA
Cash Flow after changes in Working CapitalNANANA
Cash Flow from Operating ActivitiesNANANA
Cash Flow from Investing ActivitiesNANANA
Cash Flow from Financing ActivitiesNANANA
Net Cash Inflow / OutflowNANANA
Opening Cash & Cash EquivalentsNANANA
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANA
Effect of Foreign Exchange FluctuationsNANANA
Closing Cash & Cash EquivalentNANANA

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.